Rail Vision Ltd Ordinary Share (RVSN) had the highest return between December 1, 2023 and January 31, 2024 by a US stock in the Nasdaq Composite (IXIC), returning 1,207%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rail Vision Ltd Ordinary Share (RVSN) | 12/1/2023 - 1/31/2024 | 1,207.02% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 12/1/2023 - 1/31/2024 | 1,005.65% |
Shattuck Labs (STTK) | 12/1/2023 - 1/31/2024 | 421.55% |
Swvl (SWVL) | 12/1/2023 - 1/31/2024 | 416.13% |
Eyepoint Pharmaceuticals (EYPT) | 12/1/2023 - 1/31/2024 | 334.35% |
Corbus Pharmaceuticals (CRBP) | 12/1/2023 - 1/31/2024 | 307.54% |
C4 Therapeutics (CCCC) | 12/1/2023 - 1/31/2024 | 286.25% |
Sezzle (SEZL) | 12/1/2023 - 1/31/2024 | 280.28% |
CCSC Technology International Holdings Limited Ordinary Shares (CCTG) | 12/1/2023 - 1/31/2024 | 268.52% |
Sera Prognostics (SERA) | 12/1/2023 - 1/31/2024 | 268.42% |
Compugen (CGEN) | 12/1/2023 - 1/31/2024 | 265.15% |
Cadrenal Therapeutics, Inc Common Stock (CVKD) | 12/1/2023 - 1/31/2024 | 264% |
Nkarta (NKTX) | 12/1/2023 - 1/31/2024 | 251.75% |
Lixiang Education (LXEH) | 12/1/2023 - 1/31/2024 | 244.77% |
Sphere 3D (ANY) | 12/1/2023 - 1/31/2024 | 238.16% |
FibroGen (FGEN) | 12/1/2023 - 1/31/2024 | 236.84% |
Inhibikase Therapeutics (IKT) | 12/1/2023 - 1/31/2024 | 235.06% |
Garden Stage Limited Ordinary Shares (GSIW) | 12/1/2023 - 1/31/2024 | 223.15% |
Mawson Infrastructure (MIGI) | 12/1/2023 - 1/31/2024 | 220.29% |
Invivyd (IVVD) | 12/1/2023 - 1/31/2024 | 218% |
Arcutis Biotherapeutics (ARQT) | 12/1/2023 - 1/31/2024 | 217.3% |
Century Therapeutics (IPSC) | 12/1/2023 - 1/31/2024 | 210.14% |
Edgewise Therapeutics (EWTX) | 12/1/2023 - 1/31/2024 | 196.18% |
Dave (DAVE) | 12/1/2023 - 1/31/2024 | 193.39% |
Astria Therapeutics (ATXS) | 12/1/2023 - 1/31/2024 | 178.42% |
